Abingworth as of June 30, 2019
Portfolio Holdings for Abingworth
Abingworth holds 14 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Personalis Common (PSNL) | 56.7 | $148M | 5.4M | 27.15 | |
| Crispr Namen Akt (CRSP) | 21.1 | $55M | 1.2M | 47.00 | |
| Sientra Common | 5.6 | $15M | 2.4M | 6.15 | |
| Avedro Common | 5.4 | $14M | 719k | 19.58 | |
| Soleno Common | 4.7 | $12M | 4.7M | 2.60 | |
| Verona Sponds Adr (VRNA) | 1.7 | $4.5M | 902k | 5.03 | |
| Paratek Common | 1.6 | $4.1M | 1.0M | 3.96 | |
| Chiasma Common | 1.4 | $3.6M | 478k | 7.44 | |
| Aeglea Common | 0.6 | $1.6M | 241k | 6.81 | |
| Obseva Common | 0.4 | $985k | 88k | 11.19 | |
| Cymabay Common | 0.4 | $937k | 131k | 7.15 | |
| Proteon Common | 0.3 | $851k | 2.0M | 0.42 | |
| Sierra Oncology Common | 0.0 | $121k | 217k | 0.56 | |
| Histogenics Common | 0.0 | $84k | 427k | 0.20 |
